CCDC102A Activators
Forskolin and IBMX that work by manipulating the levels of secondary messengers such as cAMP, which in turn can activate kinases like PKA, to compounds like PMA and Ionomycin that activate PKC and increase intracellular calcium levels, respectively. These events can lead to the activation of kinases capable of phosphorylating CCDC102A.
Additionally, compounds like LY294002, PD98059, and Genistein target specific kinases and signaling pathways that can culminate in the modulation of CCDC102A activity, either by altering its phosphorylation state or by affecting the cellular processes that CCDC102A is involved in. Epigenetic modulators such as Trichostatin A and 5-Azacytidine can also indirectly influence CCDC102A by affecting the expression levels of genes. Metabolic pathways play a role as well, with AICAR activating AMPK that can impact the activity of CCDC102A through metabolic signals. Stress pathway activators like Anisomycin and protein phosphatase inhibitors such as Okadaic Acid can also play a role in modulating the activity of proteins like CCDC102A by altering the balance of phosphorylation within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Inhibits phosphodiesterases leading to increased cAMP, possibly enhancing phosphorylation of CCDC102A by protein kinase A. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC, which may phosphorylate CCDC102A if it is a PKC substrate. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Elevates intracellular calcium, potentially activating kinases that could phosphorylate CCDC102A. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Inhibits tyrosine kinases, possibly affecting phosphorylation status and activity of CCDC102A. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, potentially affecting downstream signaling that could modulate CCDC102A activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, potentially affecting MAPK/ERK pathway signaling and CCDC102A phosphorylation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Inhibits histone deacetylases, which could lead to changes in gene expression and potentially increase CCDC102A expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Inhibits DNA methyltransferases, potentially upregulating genes including possibly CCDC102A. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activates AMPK, which may influence metabolic pathways and modulate CCDC102A activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates JNK and p38 MAP kinase pathways, which may lead to altered activity of CCDC102A. | ||||||